Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    BARDA Chem and RadNuc Animal Model Development

    By Global Biodefense StaffDecember 10, 2014
    Credit: Shutterstock
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA) has issued a notice seeking laboratory research services to establish new or existing animal models for the development of Chemical and Radiological/Nuclear Medical Countermeasures (MCMs).

    BARDA anticipates that contracts awarded from effort will serve to facilitate the animal model development of medical countermeasures and supportive reagents and assays for regulatory acceptance in the U.S.

    In these models, the challenge dose generally should be the same as that which produces the human disease or condition and the pathophysiological mechanism of its toxicity should be reasonably well-understood and mimic the human condition as closely as possible.

    When these models are used to test the efficacy of potential MCMs for threat agents, the mechanism of action of the countermeasure will need to establish the utility of the animal model as a surrogate for humans.

    It is anticipated that the official RFP will be released January 20, 2015, with proposals being due on or about March 4, 2015. Multiple awards may result from this solicitation with an estimated award date in July 2015.

    Further details are available under Solicitation Number: RFP-15-100-SOL-00004.

    Editor’s Note: The release date for the RFP was postponed until on/about Mar 17, 2015.

    Animal Models ASPR BARDA Chemical Detection HHS Radiation
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiological Engagement Training in Laos
    Next Article NIH Award to Rutgers to Advance Cepheid Ebola Diagnostic

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.